Cargando…

Special Issue “Diagnostic Biomarkers in Prostate Cancer 2020”

Detalles Bibliográficos
Autor principal: Neuhaus, Jochen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001763/
https://www.ncbi.nlm.nih.gov/pubmed/33809229
http://dx.doi.org/10.3390/diagnostics11030505
_version_ 1783671306204479488
author Neuhaus, Jochen
author_facet Neuhaus, Jochen
author_sort Neuhaus, Jochen
collection PubMed
description
format Online
Article
Text
id pubmed-8001763
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80017632021-03-28 Special Issue “Diagnostic Biomarkers in Prostate Cancer 2020” Neuhaus, Jochen Diagnostics (Basel) Editorial MDPI 2021-03-12 /pmc/articles/PMC8001763/ /pubmed/33809229 http://dx.doi.org/10.3390/diagnostics11030505 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Editorial
Neuhaus, Jochen
Special Issue “Diagnostic Biomarkers in Prostate Cancer 2020”
title Special Issue “Diagnostic Biomarkers in Prostate Cancer 2020”
title_full Special Issue “Diagnostic Biomarkers in Prostate Cancer 2020”
title_fullStr Special Issue “Diagnostic Biomarkers in Prostate Cancer 2020”
title_full_unstemmed Special Issue “Diagnostic Biomarkers in Prostate Cancer 2020”
title_short Special Issue “Diagnostic Biomarkers in Prostate Cancer 2020”
title_sort special issue “diagnostic biomarkers in prostate cancer 2020”
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001763/
https://www.ncbi.nlm.nih.gov/pubmed/33809229
http://dx.doi.org/10.3390/diagnostics11030505
work_keys_str_mv AT neuhausjochen specialissuediagnosticbiomarkersinprostatecancer2020